Janney Montgomery Scott
ACAD icon

Janney Montgomery Scott’s Acadia Pharmaceuticals ACAD Stock Holding History

Janney Montgomery Scott’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$522K Buy
+23,472
New +$561K ﹤0.01% 2017
2021
Q1 		– Sell
-4,060
Closed -$217K – 2165
2020
Q4 		$217K Buy
+4,060
New +$202K ﹤0.01% 2060

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Janney Montgomery Scott's ACAD Position: Q1 2026 in Review

Janney Montgomery Scott opened a new position in Acadia Pharmaceuticals (ACAD) in Q1 2026: 23,472 shares worth $522K. The stake represents ﹤0.01% of the portfolio and ranks #2017 among its holdings. This is a return to the name: Janney Montgomery Scott previously reported a position in ACAD as recently as Q4 2020.

Janney Montgomery Scott first reported a position in ACAD in Q4 2020 and has held it in 2 quarters since. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Janney Montgomery Scott held 23,472 shares of Acadia Pharmaceuticals worth $522K as of Q1 2026.
  • Acadia Pharmaceuticals was a new Janney Montgomery Scott position in Q1 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #2017 holding.
  • Janney Montgomery Scott first reported a position in Acadia Pharmaceuticals in Q4 2020 and has held it in 2 quarters since.
  • 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.